← Back to Clinical Trials
Recruiting NCT06194708

NCT06194708 Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06194708
Status Recruiting
Phase
Sponsor Peking Union Medical College Hospital
Condition Rectal Cancer
Study Type OBSERVATIONAL
Enrollment 235 participants
Start Date 2023-05-15
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 235 participants in total. It began in 2023-05-15 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn about in mid-low rectal patients who received temporary ostomies after surgery of the primary tumors. The main questions it aims to answer are: * To explore the proportion of temporary stomas that cannot be reversed after radical surgery for mid-low rectal cancer and their main causes. * To use the basic information we collected from patients before and during surgery to develop an individualized model for predicting the time of stoma reversal and explore the risk factors affecting stoma reversal.

Eligibility Criteria

Inclusion Criteria: * Pathologically confirmed as rectal adenocarcinoma; * The tumor is located within 12cm from the anal verge; * Primary tumor is radically resected; * The patient received a temporary ostomy during the in-hospital visit of the resection of the primary tumor. Exclusion Criteria: * The stoma was initially recognized as permanent stoma; * Patients with distant metastasis; * Patients with multi-primary colorectal cancer.

Frequently Asked Questions

Who can join the NCT06194708 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Rectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06194708 currently recruiting?

Yes, NCT06194708 is actively recruiting participants. Visit ClinicalTrials.gov or contact Peking Union Medical College Hospital to inquire about joining.

Where is the NCT06194708 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06194708 clinical trial?

NCT06194708 is sponsored by Peking Union Medical College Hospital. The trial plans to enroll 235 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology